Palantir’s Q2 earnings impress, but slowing beat momentum raises valuation risks. Learn why cautious investors may wait for weakness before buying in PLTR stock.
Palantir’s Consensus Beating Momentum Is A Ticking Time Bomb For Investors
view original post